You are here: Home News PhinC Development presents its achievement with GastroPlus® software

PhinC Development presents its achievement with GastroPlus® software

Meet us at the Génocentre, Evry (France) on May 20th 2014 to discover how GastroPlus® software have been useful to biotechnology companies.

In October 2012, PhinC announced the acquisition of Gatroplus® software. More than one year later we will offer you a feedback on what we have been able to accomplish with that powerful tool.

As a Genopolitan plateform, the study will be presented at the Génocentre, Evry on May 20th 2014 during the “Journée Plates-formes”

If you need more information visit Genopole website at http://www.genopole.fr/journée-plates-formes-2014

About GastroPlus®

GastroPlus® is a software allowing to perform Physiologically based pharmacokinetic studies (PBPK). This pharmacometrics technique is particularly useful to help developers to study different animal models or to go from preclinical studies to Phase I clinical study. With GastroPlus®, we can build pharmacokinetic models (from actual preclinical data) and develop some predictions about the drug candidate future into human organism. Using GastroPlus® software allows to radically optimize the critical step before First-in-Men study.

Find out more about our PBPK services -->